Business
MedX(R) Health Corp. Reports Second Quarter 2008 Financial Results
MISSISSAUGA, ON, Aug. 22 /CNW/ - MedX Health Corp., a leading North American developer and manufa...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\n\nMISSISSAUGA, ON, Aug. 22 /CNW/ - MedX Health Corp., a leading North\nAmerican developer and manufacturer of low level laser medical devices,\nincluding dental, rehabilitation and wound care products today announced its\nresults for the three months ended June 30, 2008.\n\n\nRevenue for the three months ended June 30, 2008 was $259,235 compared to\n$344,885 for the three months ended June 30, 2007 a 25% decrease versus the\nsame period last year.\n\n\nMedX incurred a net loss of $817,465 in Q2 2008 compared to a net loss of\n$495,952 for the same period in the prior year.\n\n\n"Moving forward, we remain on track in our commitment to expand our\nproducts and services internationally via new distribution channels, novel\nproduct technology, strategic partnerships and strong IP programs. Our recent\naccomplishments are testaments to this strategic shift," said Steven Guillen,\nchief executive officer and president of MedX Health.\n\n\nRecent Company Achievements:\n- Filed Provisional Patent Application with the U.S. Patent Office for\n Photobandage(TM) (May 20, 2008)\n- Low-level laser wound healing study was published in the\n International Wound Journal and presented at the World Union of Wound\n Healing Societies Congress in June in Toronto (June 5, 2008)\n- Announced promotion of Steve Guillen to Chief Executive Officer and\n President (June 27, 2008)\n- Announced strategic partnership with Technology4Medicie to become\n Medx Health's exclusive U.S. dental distributor for Oralase(TM)\n (July 15, 2008)\n- Closed non-brokered private placement of 4,300,000 common shares for\n CAD$1,075,000 (August 5, 2008)\n\n-------------------------------------------------------------------------\nCanadian $ Q2 2008 Q2 2007\n-------------------------------------------------------------------------\nRevenue 259,235 344,885\n-------------------------------------------------------------------------\nGross Margin % 88% 75%\n-------------------------------------------------------------------------\nIncome (Loss) from continued operations (823,190) (496,070)\n-------------------------------------------------------------------------\nIncome (Loss) from discontinued operations 5,725 118\n-------------------------------------------------------------------------\nNet Income (Loss) for period (817,465) (495,952)\n-------------------------...